ELCV yields 1.73% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 7
Combined, ELCV + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ELCV + JNJ for your $10,000?
ELCV invests in dividend-paying securities, seeking to deliver competitive returns while aligning investments with broader social and environmental goals. The fund aims to achieve a higher average dividend yield than the Bloomberg US 3000 Total Return Index. Portfolio selection combines fundamental research with a commitment to ethical, value-based principles. Initially, it employs a bottom-up research process, evaluating financial strength, dividend potential, and stakeholder value creation. The fund then applies a values-based screening rooted in Christian principles, avoiding industries like tobacco, alcohol, gambling, and weapons. Instead, it favors companies that exhibit responsible management, social justice, and environmental stewardship. While the fund primarily holds large-cap US stocks, it may also include ADRs. Investment focuses on sectors traditionally known for high dividends or growth, such as energy, utilities, industrials, technology, infrastructure, and real estate.
Full ELCV Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.